Tirzepatide on TikTok: separating real results from hype

What did @katyaalanis_ actually say?

Honestly? Very little. The transcript is largely incoherent, looping through the phrase "the same color" four times with no clear meaning. The creator tells viewers to "like the video" to learn more, and mentions showing how to "read about this video." There are no medical claims, dosage instructions, or weight loss assertions in the spoken content.

The hashtags tell a more specific story: #tirzepatide, #wheightloss, and #inyeciones (injections) suggest this video is positioned within the GLP-1 weight loss conversation on TikTok. The caption tags Remake Beauty Studio and Mona Trevino, hinting at a local beauty or wellness business context, likely in the Rio Grande Valley region based on the #rgv hashtag. But none of this context appears in the spoken transcript.

Bottom line: there are no verifiable spoken claims to evaluate here. What we can do is use the video's implied topic, tirzepatide and weight loss, to give viewers the context they actually need.

Does the science back this up?

Since no specific claims were made, there is nothing to confirm or refute directly. But tirzepatide itself is one of the better-studied weight loss drugs available right now, and the science is genuinely worth knowing.

Tirzepatide is a dual GIP and GLP-1 receptor agonist, which means it works on two metabolic pathways simultaneously. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) found that patients on the highest dose (15 mg weekly) lost an average of 20.9% of their body weight over 72 weeks, compared to 3.1% for placebo. That is a meaningful result by any reasonable standard.

A follow-up analysis (Wadden et al., 2023, Nature Medicine) reinforced that the weight loss was largely sustained with continued use, and that discontinuation led to significant regain. This matters for anyone seeing injection-related content on social media and assuming tirzepatide is a one-and-done fix.

The drug is FDA-approved under the brand name Zepbound for chronic weight management and as Mounjaro for type 2 diabetes.

What did they get wrong (or right)?

There is nothing specific enough in the transcript to call wrong. The creator made no dosing claims, no cure claims, and no comparisons between branded and compounded versions. That absence of misinformation is, in a strange way, the cleanest part of this video.

What is worth flagging is the broader context. Beauty studios offering or promoting tirzepatide injections, which the hashtags and account tags imply, is a pattern that raises real regulatory questions. The FDA has issued warnings about tirzepatide compounding (FDA, 2024), noting that compounded versions are not FDA-approved and may differ in formulation, concentration, and sterility from Zepbound or Mounjaro.

If a beauty studio is administering tirzepatide outside of a licensed medical provider relationship, that is a serious concern, regardless of what is or is not said in any given TikTok. The framing of weight loss injections as a beauty service, rather than a medical treatment, can mislead people about what informed consent, medical screening, and ongoing monitoring actually require.

What should you actually know?

Tirzepatide works, and the clinical evidence is solid. But the drug has side effects including nausea, vomiting, gastroparesis risk, and potential pancreatitis, that require proper medical oversight. A 2023 study in JAMA Internal Medicine (Sodhi et al.) found GLP-1 users had significantly higher rates of pancreatitis and bowel obstruction compared to users of bupropion-naltrexone.

Anyone interested in tirzepatide should be screened by a licensed provider, not a beauty studio. They should discuss their full medication list, any history of pancreatitis or thyroid cancer, and realistic expectations for weight regain if they stop. The SURMOUNT-4 trial (Aronne et al., 2024, JAMA) showed a mean weight regain of 14 percentage points within one year of discontinuation.

If you are considering tirzepatide through a telehealth platform or local provider, ask whether the product is FDA-approved and brand-name, or compounded. Those are not the same thing, and the FDA explicitly states they should not be treated as interchangeable.